Efficient Fas-ligand gene expression in rodent liver after intravenous injection of a recombinant adenovirus by the use of a Cre-mediated switching system

被引:47
作者
Okuyama, T
Fujino, M
Li, XK
Funeshima, N
Kosuga, M
Saito, I
Suzuki, S
Yamada, M
机构
[1] Natl Childrens Med Res Ctr, Dept Genet, Setagaya Ku, Tokyo 1548509, Japan
[2] Natl Childrens Med Res Ctr, Dept Expt Surg, Tokyo 1548509, Japan
[3] Keio Univ, Sch Med, Dept Pediat, Tokyo 108, Japan
[4] Univ Tokyo, Inst Med Sci, Genet Mol Lab, Tokyo, Japan
关键词
recombinant adenovirus; Cre-mediated recombination; Fas-mediated apoptosis;
D O I
10.1038/sj.gt.3300704
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
An adenovirus vector AxCALNFasL was constructed in order to transduce a gene for rat Fas-ligand, requiring co-expression of Cre recombinase for ifs expression. In the cosmid cassette, pAxCALNFasL, a stuffer DNA fragment flanked with two loxP sequences was placed between the promoter and Fas-ligand cDNA to prevent its expression in transfected 293 cells. COS-7 cells infected with AxCALNFasL alone did not induce apoptosis in cocultivated Jurkat cells, hut the cells treated with AxCALNFasL and AxCANCre (an adenovirus expressing Cre recombinase with the CAG promoter) did. BALB/c mice injected with 10(9) plaque-forming units of AxCALNFasL and with different doses of AxCANCre, developed lethal acute liver failure. The number of the apoptotic hepatocytes increased dramatically with increased doses of injected AxCANCre, indicating that the level of transgene expression in the rodent liver appeared to be adjustable. Based on these observations, we conclude that Vectors expressing a gene to produce cytotoxic substances can be constructed by the use of a Cre-mediated switching system. Our system also demonstrated that efficient expression of the toxic gene in the rodent liver was achievable by co-infection of adenovirus vectors carrying the target gene and Cre recombinase.
引用
收藏
页码:1047 / 1053
页数:7
相关论文
共 27 条
[1]   Inhibition of the alloantibody response by CD95 ligand [J].
Arai, H ;
Chan, SY ;
Bishop, DK ;
Nabel, GJ .
NATURE MEDICINE, 1997, 3 (08) :843-848
[2]   Gene transfer of Fas ligand induces tumor regression in vivo [J].
Arai, H ;
Gordon, D ;
Nabel, EG ;
Nabel, GJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (25) :13862-13867
[3]   A ROLE FOR CD95 LIGAND IN PREVENTING GRAFT-REJECTION [J].
BELLGRAU, D ;
GOLD, D ;
SELAWRY, H ;
MOORE, J ;
FRANZUSOFF, A ;
DUKE, RC .
NATURE, 1995, 377 (6550) :630-632
[4]   Bystander effects of different enzyme-prodrug systems for cancer gene therapy depend on different pathways for intercellular transfer of toxic metabolites, a factor that will govern clinical choice of appropriate regimes [J].
Denning, C ;
Pitts, JD .
HUMAN GENE THERAPY, 1997, 8 (15) :1825-1835
[5]   FAS LIGAND-INDUCED APOPTOSIS AS A MECHANISM OF IMMUNE PRIVILEGE [J].
GRIFFITH, TS ;
BRUNNER, T ;
FLETCHER, SM ;
GREEN, DR ;
FERGUSON, TA .
SCIENCE, 1995, 270 (5239) :1189-1192
[6]  
Kanai F, 1997, CANCER RES, V57, P461
[7]   EFFICIENT GENE ACTIVATION IN MAMMALIAN-CELLS BY USING RECOMBINANT ADENOVIRUS EXPRESSING SITE-SPECIFIC CRE RECOMBINASE [J].
KANEGAE, Y ;
LEE, G ;
SATO, Y ;
TANAKA, M ;
NAKAI, M ;
SAKAKI, T ;
SUGANO, S ;
SAITO, I .
NUCLEIC ACIDS RESEARCH, 1995, 23 (19) :3816-3821
[8]   Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction [J].
Kang, SM ;
Schneider, DB ;
Lin, ZH ;
Hanahan, D ;
Dichek, DA ;
Stock, PG ;
Baekkeskov, S .
NATURE MEDICINE, 1997, 3 (07) :738-743
[9]   Essential roles of the Fas ligand in the development of hepatitis [J].
Kondo, T ;
Suda, T ;
Fukuyama, H ;
Adachi, M ;
Nagata, S .
NATURE MEDICINE, 1997, 3 (04) :409-413
[10]   ICE-protease inhibitors block murine liver injury and apoptosis caused by CD95 or by TNF-alpha [J].
Kunstle, G ;
Leist, M ;
Uhlig, S ;
Revesz, L ;
Feifel, R ;
MacKenzie, A ;
Wendel, A .
IMMUNOLOGY LETTERS, 1997, 55 (01) :5-10